Yahoo Web Search

  1. Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the nine-month functional results from three Limb-girdle muscular ...

  2. An experimental Amgen Inc drug that targets a specific genetic mutation shrank tumors in just one of 12 patients with advanced colorectal cancer who were given the highest dose ...

  3. Edited Transcript of SUMM.L earnings conference call or presentation 11-Oct-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceOct 15 5:18 AM

    Thank you, and welcome to everyone joining us on the call today to discuss our financial results for the second quarter and half year ended July 31, 2019. Earlier today, we issued a press release ...